Abstract 10838: Impact of Diabetes on Soluble Fms-Like Tyrosine Kinase-1 and Cardiovascular Events in Patients with Suspected or Known Coronary Artery Disease: The EXCEED-J Study

Hiromichi Wada,Tsuyoshi Shinozaki,Masahiro Suzuki,Satoru Sakagami,Junichi Funada,Morihiro Matsuda,Masatoshi Shimizu,Takashi Takenaka,Yukiko Morita,Kazuya Yonezawa,Hiromi Matsubara,Yujiro Ono,Toshihiro Nakamura,Kazuteru Fujimoto,Akiyo Ninomiya,Toru Kato,Takashi Unoki,Daisuke Takagi,Kyohma Wada,Moritake Iguchi,Kazuhiko Kotani,Mitsuru Abe,Masaharu Akao,Koji Hasegawa

Abstract 10838: Impact of Diabetes on Soluble Fms-Like Tyrosine Kinase-1 and Cardiovascular Events in Patients with Suspected or Known Coronary Artery Disease: The EXCEED-J Study

2021

Background: Whether diabetes mellitus (DM) modifies the relationship between soluble fms-like tyrosine kinase-1 (sFlt-1), a vascular endothelial growth factor (VEGF) antagonist, and cardiovascular ...

Keywords:

Antagonist
Vascular endothelial growth factor
Known Coronary Artery Disease
Diabetes mellitus
Internal medicine
Endocrinology
Tyrosine
Soluble fms-like tyrosine kinase-1
Medicine
Coronary artery disease
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations